Hamtaei-Gashti S

No ORCID on file · 1 paper in corpus · active 2025
2025
Current journal of neurology ·doi:10.18502/cjn.v24i2.20684

Background: The major treatment regimens for multiple sclerosis (MS) are disease-modifying therapies (DMTs). Fungal, viral, and bacterial infections are common complications of these drugs. Also, MS itself is an immune-related chronic disea…